Does MONTELUKAST Cause Psychomotor hyperactivity? 282 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 282 reports of Psychomotor hyperactivity have been filed in association with MONTELUKAST (Montelukast). This represents 1.1% of all adverse event reports for MONTELUKAST.
282
Reports of Psychomotor hyperactivity with MONTELUKAST
1.1%
of all MONTELUKAST reports
0
Deaths
29
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From MONTELUKAST?
Of the 282 reports, 29 (10.3%) required hospitalization, and 9 (3.2%) were considered life-threatening.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MONTELUKAST. However, 282 reports have been filed with the FAERS database.
What Other Side Effects Does MONTELUKAST Cause?
Asthma (8,372)
Dyspnoea (6,354)
Wheezing (5,159)
Drug ineffective (3,539)
Cough (3,475)
Therapeutic product effect incomplete (3,352)
Anxiety (2,994)
Loss of personal independence in daily activities (2,736)
Sleep disorder due to a general medical condition (2,101)
Obstructive airways disorder (2,073)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
LORAZEPAM (197)
Which MONTELUKAST Alternatives Have Lower Psychomotor hyperactivity Risk?
MONTELUKAST vs MONTELUKAST\MONTELUKAST
MONTELUKAST vs MONTMORILLONITE
MONTELUKAST vs MORNIFLUMATE
MONTELUKAST vs MOROCTOCOG ALFA
MONTELUKAST vs MORPHINE